8-K
Current Report
Jasper Therapeutics, Inc. Filed Acc 0001213900-25-061471
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading ea0248135-8k_jasper.htm…